QUANTITATIVE SIMULTANEOUS DETERMINATION OF ALISKIREN HEMIFUMARATE AND HYDROCHLOROTHIAZIDE IN COMBINED TABLET FORMULATION BY RP-HPLC

Abstract

Objective: Development and validation of quantitative simultaneous determination of aliskiren hemifumarate (ALI) and hydrochlorothiazide (HCT) in combined tablet formulation by RP-HPLC.Methods: The separation of components were achieved on Enable C18 column (250×4.6 mm, 5 µm) with a mobile phase consisting of 0.2 %v/v triethylamine in water (pH 6 was adjusted with orthophosphoric acid): methanol (10:90 %v/v) at a flow rate of 1 ml/min was employed. Quantification was achieved with PDA detection at 280 nm. Validation parameters of the proposed method such as specificity, linearity, accuracy, precision and robustness were evaluated according to ICH guidelines.Results: Linear concentration range was between 1.2-240 µg/ml for ALI and 0.1-20 µg/ml for HCT and correlation coefficient was found to be 0.9995 and 0.9998, respectively. The limit of detection and limit of quantification for ALI was found to be 0.3376 and 1.0230 µg/ml and for HCT 0.0288 and 0.0873 µg/ml, respectively. The results of precision (% RSD<2) studies showed good reproducibility. Recovery study was performed at 50, 100 and 150 % level to check the interferences between analytes and formulation excipients and % recovery was found to be 99.49±0.9868 for ALI and 99.87±0.8556 for HCT. The percentage assay was found to be 100.36±0.9201 and 99.40±0.7624 for ALI and HCT, respectively.Conclusion: A simple, rapid, cost effective and highly sensitive RP-HPLC method as compared to existing methods for the determination of ALI and HCT in tablet formulation was developed and validated as per ICH guidelines. The method uses simple reagents and sample preparation procedures were minimal. Thus, the proposed method can be applied for routine quality control determination of ALI and HCT in tablet formulation. 

Authors and Affiliations

Ashim K Sen, Dhanya B Sen, Rajesh A Maheshwari, R Balaraman, A K Seth

Keywords

Related Articles

DOSE OPTIMIZATION OF CEFTRIAXONE-SULBACTAM COMBINATION IN ADULTS USING IN VITRO SYSTEMS, PK/PD MODELING AND STOCHASTIC SIMULATIONS APPROACHES

Objective: To optimize the dosage regimen of fixed-dose combination (FDC) of ceftriaxone/sulbactam (2/1 w/w) using in vitro system, pharmacokinetic/pharmacodynamic (PK/PD) modeling and Monte-Carlo simulations (MCS).Metho...

A REVIEW ON ANTI-INFLAMMATORY POTENTIAL OF SUBSTITUTED PYRAZOLINE DERIVATIVES SYNTHESISED FROM CHALCONES

The pyrazoline ring is a ubiquitous structural feature of many natural and synthetic compounds with potent anti-inflammatory activity. The creation of novel pyrazoline derivatives and examination of their chemical and bi...

ANTIBIOTIC SENSITIVITY PATTERN OF CITROBACTER SPP. ISOLATED FROM PATIENTS WITH URINARY TRACT INFECTIONS IN TERTIARY CARE HOSPITAL IN SOUTH INDIA

Objectives: Urinary tract infection (UTIs) caused by Citrobacter species have been described in 5 to 12% of bacterial urine isolates in adults. The genus Citrobacter is a distinct group of aerobic Gram-negative bacilli f...

ANTIOXIDANT ACTIVITY AND ANTIPROLIFERATIVE ACTION OF METHANOLIC EXTRACT OF LIQUORICE (GLYCYRRHIZA GLABRA) IN HEPG2 CELL LINE

Objective: To evaluate the in vitro antioxidant activity of liquorice (Glycyrrhiza glabra) against H2O2 induced oxidative stress in HepG2 cell line.Methods: Antioxidant activity of methanolic extracts of Glycyrrhiza glab...

FORMULATION AND EVALUATION OF AN HERBAL ANTI-INFLAMMATORY GEL CONTAINING TRIGONELLA FOENUM GREACUM SEED EXTRACT

Objective: The present study was aimed to develop topical gel containing Trigonella foenum greacum (fenugreek) seed extract using carbopol-934, Hydroxypropyl methylcellulose K4M (HPMC K4M) as gelling agents and to invest...

Download PDF file
  • EP ID EP578277
  • DOI -
  • Views 94
  • Downloads 0

How To Cite

Ashim K Sen, Dhanya B Sen, Rajesh A Maheshwari, R Balaraman, A K Seth (2015). QUANTITATIVE SIMULTANEOUS DETERMINATION OF ALISKIREN HEMIFUMARATE AND HYDROCHLOROTHIAZIDE IN COMBINED TABLET FORMULATION BY RP-HPLC. International Journal of Pharmacy and Pharmaceutical Sciences, 7(8), 142-145. https://europub.co.uk/articles/-A-578277